Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Actinic Keratosis Treatment Market
Actinic Keratosis Treatment Market Size
- Report ID: GMI5859
- Published Date: May 2023
- Report Format: PDF
Actinic Keratosis Treatment Market Size
Actinic Keratosis Treatment Market size accounted for USD 5.5 billion in 2022 and is estimated to grow at 5.5% to reach USD 9.7 billion by 2032. Rising prevalence of actinic keratosis coupled with growing demand for minimally invasive procedures.
For instance, according to American Academy of Dermatology Association 2019 report, more than 40 million Americans develop actinic keratoses (AKs) each year. Thus, increase in the prevalence of actinic keratosis is propelling the demand for minimally invasive procedures such as photodynamic therapy, thereby driving the market growth. Also, growing awareness pertaining to actinic keratosis and various strategic initiatives undertaken by key market players is expected to propel the market progression.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Actinic Keratosis Treatment Market Size in 2022: | USD 5.5 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 5.5% |
| 2032 Value Projection: | USD 9.7 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 150 |
| Tables, Charts & Figures: | 296 |
| Segments covered: | Therapy, Drug Class, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Actinic keratosis (AK) refers to a precancerous skin condition characterized by rough, scaly patches or lesions on areas of the body such as such as the face, scalp, ears, and hands that have been exposed to the sun. It is primarily caused by long-term ultraviolet (UV) radiation exposure from the sun or tanning beds. AK is considered a pre-malignant condition, meaning that if left untreated, it has the potential to progress into a type of skin cancer known as squamous cell carcinoma.
Frequently Asked Questions (FAQ) :
Actinic Keratosis Treatment Market Scope
